Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Oracle Corporation, 3 years.
Oracle Corporation
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Oracle Corporation November 18, 202592.2%
-
Oracle Corporation November 14, 202480.1%
-
Oracle Corporation November 15, 202378.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 31, 2026 | Oracle Corporation | Option exercise | +2,114 | — | — |
| Oct 28, 2025 | Oracle Corporation | Open-market sale | −9,042 | $281.58 | $2,546,046 |
| Oct 28, 2025 | Oracle Corporation | Open-market sale | −13,373 | $282.56 | $3,778,675 |
| Oct 28, 2025 | Oracle Corporation | Open-market sale | −22,724 | $283.63 | $6,445,208 |
| Oct 28, 2025 | Oracle Corporation | Open-market sale | −4,226 | $284.31 | $1,201,494 |
| May 31, 2025 | Oracle Corporation | Option exercise | +2,986 | — | — |
| May 14, 2025 | Oracle Corporation | Gift | −12,334 | — | — |
| Jun 20, 2024 | Oracle Corporation | Option exercise | +22,500 | $43.49 | $978,525 |
| Jun 20, 2024 | Oracle Corporation | Open-market sale | −8,175 | $142.68 | $1,166,409 |
| Jun 20, 2024 | Oracle Corporation | Open-market sale | −14,325 | $143.36 | $2,053,632 |
| May 31, 2024 | Oracle Corporation | Option exercise | +3,303 | — | — |
| Mar 18, 2024 | Oracle Corporation | Option exercise | +45,000 | $42.02 | $1,890,900 |
| Mar 18, 2024 | Oracle Corporation | Open-market sale | −39,833 | $127.73 | $5,087,869 |
| Mar 18, 2024 | Oracle Corporation | Open-market sale | −5,167 | $128.31 | $662,978 |
| Jun 15, 2023 | Oracle Corporation | Open-market sale | −4,866 | $125.31 | $609,758 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.